5Dusick JR, Gonzalez NR. Management of arterial vasospasmfollowing aneurysmal subarachnoid hemorrhage [J]. SeminNeurol,2013,33(5) =488-497.
6Wu S.Sena E> Egan K,et al. Edaravone improves functionaland structural outcomes in animal models of focal cerebralischemia: a systematic review [J]. Int J Stroke, 2014 *9(1):101-106.
7Li T, Wang N,Zhao M. Neuroprotective effect of' phosphocreatine on focal cerebral ischemia-reperfusion injury[J].J Biomed Biotechnol,2012,2012; 168756.
8Lyden P,Raman R,Liu L,et al.National Institutes of HealthStroke Scale certification is reliable across multiple venues[J].Stroke,2009,40(7) :2507-2511.
9Lee Y, Zuckerman SL, Mocco J. Current controversies in theprediction,diagnosis,and management of cerebral vasospasm:where do we stand. [J].Neurol Res Int. 2013 .2013 : 373458.
10Kuhn AL,Balami JS,Grunwald IQ.Current management andtreatment of cerebral vasospasm complicating SAH[J].CNSNeurol Disord Drug Targets,2018,12(2) ;233-241.
